Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case–control study ; volume:21 ; number:1 ; day:26 ; month:8 ; year:2021 ; pages:1-10 ; date:12.2021
BMC infectious diseases ; 21, Heft 1 (26.8.2021), 1-10, 12.2021
- Creator
-
Grzegorzewska, Alicja E.
Mostowska, Adrianna
Warchoł, Wojciech
Jagodziński, Paweł P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-021-06597-4
- URN
-
urn:nbn:de:101:1-2021111119394777633334
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grzegorzewska, Alicja E.
- Mostowska, Adrianna
- Warchoł, Wojciech
- Jagodziński, Paweł P.
- SpringerLink (Online service)
Other Objects (12)
Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
Human paraoxonase 2
Kinetics of small and middle molecule clearance during continuous hemodialysis
HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?
Serum-Paraoxonase-Polymorphismus in Japan
Spontaneous clearance of serum HCV-RNA after splenectomy in a patient with HCV-related liver cirrhosis and portal hypertension: a case report
HCV
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
Human paraoxonase 2
Kinetics of small and middle molecule clearance during continuous hemodialysis
HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?
Serum-Paraoxonase-Polymorphismus in Japan
Spontaneous clearance of serum HCV-RNA after splenectomy in a patient with HCV-related liver cirrhosis and portal hypertension: a case report
HCV
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
Human paraoxonase 2
Kinetics of small and middle molecule clearance during continuous hemodialysis
HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?
Serum-Paraoxonase-Polymorphismus in Japan
Spontaneous clearance of serum HCV-RNA after splenectomy in a patient with HCV-related liver cirrhosis and portal hypertension: a case report
HCV
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response